Search Results 51-60 of 13187 for Tyrosine
This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...
... tyrosine kinase inhibitor). Your doctor will perform a test before you take this medicine. Amivantamab and hyaluronidase-lpuj combination injection is also ...
Pirfenidone, a well-known anti-fibrotic drug already approved outside the U.S., and nintedanib, a tyrosine kinase inhibitor, both became available ...
The purpose of this study is to determine the effetiveness and safety of brepocitinib (a tyrosine kinase [TYK] 2/Janus kinase [JAK] 1 inhibitor) in patients ...
Singh is studying the cell biology of the pancreatic acinar cell in health and disease, as well as the role of aberrant tyrosine phosphorylation in regulating ...
... tyrosine kinase for triple negative breast cancer and high-grade serous ovarian cancer; Developing novel technologies for quantitative proteomics ...
This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine ...
Research in the Pancreatitis and Acute Outcomes Research Lab has determined the role of the nonreceptor tyrosine kinase c-Src in the maturation and ...
Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...
The tyrosine kinase allows too many white blood cells to grow. Most or all of these cells contain the Philadelphia chromosome. The diseased white blood cells ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.